Medicines Evaluation Unit Ltd

Join our team as a Business Development Associate! 🌟 This is the perfect opportunity for someone looking to kickstart their career in business development. With full training and support, you can take your career to the next level at the MEU. More info over on our website - #BusinessDevelompment #BDJobs #Manchester

The MEU team will be attending #DDL2024 for it's 35th anniversary! Be sure to meet with our CEO (David Rogers) & BD Manager (Richard E A Smith) to discuss all that the MEU has to offer as an award-winning early phase respiratory site in Manchester. #DDL #MHRA #Asthma #COPD #Biomarkers #Bronchoscopy #LungFunction #Respiratory #ClinicalTrial

An exciting update from MHRA!   The MHRA has published its latest performance data on the assessment of clinical trials and established medicines.   Key highlights include: 🔹 Regulatory assessments for clinical trials are now more streamlined, supporting innovation while maintaining high safety standards. 🔹 Focused efforts on timely approvals ensure ground-breaking research progresses on schedule, delivering faster patient access to new treatments 🔹 Improved transparency, keeping stakeholders informed and engaged throughout the process.   This demonstrates the MHRA’s commitment to meeting timelines and positioning the UK as a global leader in life sciences and clinical research.   See full details here: https://lnkd.in/eMq5yDV5   #MHRA #LifeSciences #ClinicalResearch David Rogers Richard E A Smith

Great to see our BALF 27-Plex Biomarker Assay presented at the 17th EBF Open Symposium, please stop by and speak to Kathryn Little at poster booth A5 for more details!

Thoroughly enjoyed presenting our approach to Sputum Biomarker Assay Validation at the 17th EBF Open Symposium this afternoon. Thanks to an attentive audience for listening and some interesting conversations afterwards. Medicines Evaluation Unit Ltd

If you're attending the European Bioanalysis Forum next week, be sure to say hello to the MEU team! 👋 Dr Alex Mulvanny and Kathryn Little will be heading over to Barcelona for EBF and are excited to meet with many of our colleagues from across Europe. #bioanalysis #clinicialtrials #manchester

Today, on STEM day, MEU is proud to support Wythenshawe Hospital’s revolutionary Ion Endoluminal System, “The Bronchoscopic Robot”! David Rogers, MEU CEO said “I am delighted to support the funding of this pioneering procedure in early lung cancer diagnosis at Wythenshawe Hospital, one of the first hospitals in Europe to use the revolutionary Bronchoscopic Robot. With this donation, we are helping to speed up the detection of lung cancer in patients which is not only improving outcomes but in some cases saving lives” Through our donations to the North West Lung Centre, MEU has helped to support the adoption of this state-of-the-art robotic tool which lets doctors detect the disease in its earliest stages. Currently, diagnosing lung cancer and starting treatment can be difficult because small lung nodules are often hard to reach using traditional biopsy methods. Patients with suspected lung cancer may have to spend months of “watchful waiting” when difficult-to-reach nodules are monitored with scans but have to be allowed to grow until they are large enough to be biopsied. However, the new Ion system has a thin robotic catheter that allows doctors to quickly and accurately reach even the deepest and hardest-to-reach areas of the lungs. The system has now been used to take biopsies in the first patients with suspected lung cancer. Dr Haval Balata, Respiratory Physician and Clinical Lead for the Ion service at Manchester University NHS Foundation Trust, said that the new robot would transform how the service could treat patients as they could start treatment, or be given the all-clear, months earlier than currently may be the case. He said: “Having this new innovative technology available for our patients to access is game changing. As we have continued to successfully expand our Lung Health Check programme, we are diagnosing lung cancers at a much earlier stage when the lesions are very small and difficult to biopsy. “I’m immensely proud of our team and the trust for being one of the first centres in Europe to offer this service to their patients. Having the ability to offer patients the latest in technological advancements that enhance their care and clinical outcomes is extremely fulfilling for the team. We all very much look forward to establishing this service for patients across the region over coming weeks and months. “It’s also important to say how grateful we are to both Northwest Lung Centre charity and the MEU, without their support, we couldn’t have made this happen.” Read more about MEU and The North West Lung Centre: https://lnkd.in/d6XUrXRA #STEM #STEMday

We're LIVE for the final day of The World Vaccine Congress 📣 You can find the MEU team at stand #65 Richard E A Smith Naimat Khan David Rogers #vaccineinnovation #vaccinedevelopment #clinicaltrials #publichealth #WVC #WorldVaccineCongress

Are you attending #WorldVaccineCongress? Head to booth #65 to learn how the MEU team can help you to fast track your vaccine clinical trial! 👉 David Rogers - Chief Executive Officer 👉 Richard E A Smith - Business Development Manager 👉 Naimat Khan - Senior Research Physician #WVCEU #DrugDelivery #Vaccination #ClinicalTrials #VaccinneInnovation

Last night, David Rogers, CEO of MEU, attended the British Consulate’s Vaccines Dinner—an inspiring gathering dedicated to championing lifelong health through vaccines. This event was a powerful lead-up to The World Vaccine Congress in Barcelona, where global health leaders will soon convene to explore the future of vaccination and its impact on public health at every stage of life. With vaccination’s role in protecting communities and supporting healthier futures, this dinner marked a meaningful step toward collaboration and innovation in health. #vaccineresearch #vaccination #worldvaccinecongress #wvc #publichealth